Investigational Antibody Treatment Shows Promise for Fibrotic Lung Diseases
Preclinical data reveals CAN10’s potential to target key proteins involved in systemic sclerosis-associated interstitial lung disease and idiopathic pulmonary fibrosis.
Category: Pulmonary Fibrosis
Pulmonary Fibrosis
Latest
Pulmonary Fibrosis
Latest
Certain Mouth Bacteria Linked to Pulmonary Fibrosis Survival
Surprisingly, one bacterial species tended to dominate in certain patients with IPF who were not treated with antibiotics—and those patients were more likely to survive.
Pulmonary Fibrosis
Latest
CHEST Awards Grants to Accelerate ILD Diagnosis
CHEST announced the recipients of quality improvement grants aimed at shortening the time to diagnosis for interstitial lung disease.Â
Novel Imaging Agent Enables Early Detection of Pulmonary Fibrosis
A newly developed PET imaging agent can non-invasively identify pulmonary fibrosis in its early stages, reducing the need for unnecessary biopsies and allowing patients to begin treatment sooner.
Read More
Variant Cells Discovered in Lungs of IPF Patients
Stem cell cloning experts are reporting their findings of variant cells in the lungs of patients with idiopathic pulmonary fibrosis, which likely represent key targets in any future therapy for the condition.  Â
Read More
PFF Urges Patients to Use Only FDA-Approved Oxygen Devices
The medical advisory board of the Pulmonary Fibrosis Foundation issued a position statement on non-prescription supplemental oxygen.
Read More
Biological Clock Contributes to Lung ScarringÂ
Researchers show how a biological clock molecule, called REV-ERBα, contributes to lung scarring, uncovering new potential drugs and drug targets along the way.
Read More
Pulmonary Fibrosis Strikes Black Patients a Decade Before Non-Black Patients
Black patients with pulmonary fibrosis are significantly younger than their Hispanic and white counterparts across a wide variety of disease metrics, including diagnosis, first hospitalization, lung transplant and death.
Read More
UIC Scientists Receive $13 Million to Study Lung Inflammation Mechanisms
The researchers hope the projects will lead to new avenues for treatments to help patients with conditions like COPD, pulmonary fibrosis, and acute respiratory distress syndrome.
Read More
Pilot Study Explores Early Detection of IPF Using X-Ray and AI
The study is investigating the possibility that X-ray imaging, when used with artificial intelligence, could facilitate earlier diagnosis and eventually more effective management of idiopathic pulmonary fibrosis.
Read More
Interstitial Lung Disease in Hospitalized COVID Patients
Approximately 11% of hospitalized COVID-19 patients had fibrotic patterning after recovery from acute illness, according to a new study from Imperial College London researchers published in AJRCCM.
Read More
Airway Protein May Be Key to Body’s Mucociliary Clearance
MUC5AC, an airway protein, plays an important (and overlooked) role in the body’s mucociliary clearance system, according to research published in Science Advances.
Read More
Zinc May Reverse Pulmonary Fibrosis
Zinc, a common mineral, may reverse lung damage and improve survival for patients with idiopathic pulmonary fibrosis (IPF), according to researchers from the Women’s Guild Lung Institute at Cedars-Sinai.
Read More
Pulmonary Fibrosis Research on Access, Quality of Care
Important research results from five studies examining access to care and outcomes for patients living with pulmonary fibrosis and interstitial lung disease (ILD) are being presented at ATS 2022.
Read More
Idiopathic Pulmonary Fibrosis Clinical Practice Guidelines Issued
Updated clinical practice guidelines from ATS/ERS cover idiopathic pulmonary fibrosis and address progressive pulmonary fibrosis in patients with interstitial lung diseases other than IPF.
Read More